Histone deacetylases (HDACs) have recently garnered attention as an interesting target for neurodegenerative diseases therapies, since HDAC inhibitors can reinstate memory even after neuronal loss [31,32,33,34]. Here, HDAC9 is linked to neurodegenerative disease.